Determination of DP‐VPA and its active metabolite, VPA, in human plasma, urine, and feces by UPLC–MS/MS: A clinical pharmacokinetics and excretion study-Reference-Cited by-同舟云学术

Determination of DP‐VPA and its active metabolite, VPA, in human plasma, urine, and feces by UPLC–MS/MS: A clinical pharmacokinetics and excretion study

Published:2019-04-23 Issue:7 Volume:11 Page:1035-1047
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test Anal

Author:

Li Yi¹²³,Zhan Huizhong¹²³,Fan Yaxin¹²³,Zhang Jing¹²³,Cao Guoying¹²³,Yu Jicheng¹²³,Chen Yuancheng¹²³,Guo Beining¹²³^ORCID

Affiliation:

1. Institute of Antibiotics, Huashan Hospital, Fudan University Shanghai China

2. Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission Shanghai China

3. National Clinical Research Center for Aging and Medicine, Huashan HospitalFudan University Shanghai China

Funder

Ministry of Science and Technology of the People's Republic of China

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dta.2579

Reference18 articles.

1. New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?

2. New generation of valproic acid;Trojnar MK;Pol J Pharmacol,2004

3. The oral absorption of phospholipid prodrugs: In vivo and in vitro mechanistic investigation of trafficking of a lecithin-valproic acid conjugate following oral administration

4. Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)

5. Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An ID-HPLC–MS/MS based candidate reference measurement procedure for the quantification of valproic acid in human serum;Accreditation and Quality Assurance;2024-09-13

2. Population pharmacokinetics and exposure-safety of lipophilic conjugates prodrug DP-VPA in healthy Chinese subjects for dose regime exploring;European Journal of Pharmaceutics and Biopharmaceutics;2023-07

3. Comparative bioavailability study with two sodium valproate tablet formulations administered under fasting conditions in healthy subjects;Int. Journal of Clinical Pharmacology and Therapeutics;2022-05-01

4. Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles;Pharmaceutical Research;2021-08-31

5. Therapeutic drug monitoring of valproic acid using a dried plasma spot sampling device;Journal of Mass Spectrometry;2020-08-10